Aprea Therapeutics, Inc. (APRE)
$0.59-1.67%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 1.63
- P/E (TTM)
- -0.59
- Short % float
- 10.49%
- Days to cover
- 2.5
- SI change
- -11.4%
- 1W
- -13.24%
- 1M
- -23.38%
- vs SPY 1W
- -13.66%
- vs SPY 1M
- -25.44%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on APRE?
- LOPJLB’s latest quantitative signal on Aprea Therapeutics, Inc. (APRE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is APRE in?
- Aprea Therapeutics, Inc. (APRE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Aprea Therapeutics, Inc. (APRE) do?
- Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways. The company's primary drug candidate, ATRN-119, is an oral ATR inhibitor currently undergoing Phase 1/2a clinical trials for patients with advanced solid tumo…